42 results
8-K
EX-99.1
HOWL
Werewolf Therapeutics Inc
3 May 24
Werewolf Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
7:05am
; and the anticipated safety profile of product candidates; constitute forward-looking statements within the meaning of The Private Securities Litigation
8-K
EX-99.1
HOWL
Werewolf Therapeutics Inc
7 Mar 24
Werewolf Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
7:11am
within the meaning of The Private Securities Litigation Reform Act of 1995. The words “aim,” “anticipate,” “approach,” “believe,” “contemplate,” “continue
8-K
EX-99.2
HOWL
Werewolf Therapeutics Inc
8 Jan 24
Werewolf Therapeutics Provides Business Update and Highlights 2024 Strategic Outlook
8:08am
resources to fund the Company’s meaning of The Private Securities Litigation Reform Act of 1995. The words “aim,” foreseeable and unforeseeable operating
8-K
EX-99.1
3hj36 1v2h
8 Jan 24
Werewolf Therapeutics Provides Business Update and Highlights 2024 Strategic Outlook
8:08am
8-K
EX-99.1
qickl65w
14 Nov 23
Werewolf Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
4:34pm
8-K
js1o18g
3 Nov 23
Regulation FD Disclosure
7:05am
8-K
EX-99.2
hrcq96xe4d9v3y
3 Nov 23
Regulation FD Disclosure
7:05am
8-K
EX-99.1
sxg4g0vxv62qg34
3 Nov 23
Regulation FD Disclosure
7:05am
8-K
EX-99.1
33gz2vl zbr9zkd3mo
18 Sep 23
Regulation FD Disclosure
7:00am
8-K
EX-99.1
hnm4io97ndnoh5
10 Aug 23
Werewolf Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
7:16am
8-K
EX-99.1
c5ymbf20s e3x
11 May 23
Werewolf Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
7:05am
8-K
EX-99.1
luzn1a kt
10 Nov 22
Werewolf Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
7:05am
8-K
EX-99.1
19lvh
11 Aug 22
Werewolf Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Highlights
7:02am